Date: 23.3.2012
Researchers found that Crohn's patients who took supplementary CLA showed noticeable improvement. "In our recent open label study of CLA as a supplement in study subjects with mild to moderate CD there was a marked improvement in disease activity and quality of life in 50% of the subjects. CLA was well tolerated by all of the study subjects. These findings are very encouraging and will need to be verified in a randomized controlled trial," said Professor Kim L. Isaacs, a Professor of Gastroenterology at the University of North Carolina at Chapel Hill.
http://www.sciencedaily.com/releases/2012/03/120319194215.htm
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology organizations - Biotech research institute, company, university, ..
Animal Biotechnology - Animals, animal biotech
CRISPR-Cas10 can flood virally infected bacteria with toxic molecules, researchers discover
Toxic glass kills 99% of bone cancer without harming healthy cells